Abstract
A novel aminopeptidase B inhibitor (OF4949-III) has been synthesized from N-benzyloxycarbonyl-3,5-dibromo-L-tyrosyl-L-asparaginyl-3,4-dichloro-L-tyrosine methyl ester, whose oxidation with thallium trinitrate (TTN) as a key step followed by zinc reduction affords the corresponding diphenyl ether with the same heterocyclic skeleton as that of OF4949-III.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
